NEXGEL completes Celularity acquisition with $5.5 million financing

April 21, 2026 9:00 AM

NEXGEL Inc. (NASDAQ: NXGL) completed its acquisition of regenerative biomaterials products from Celularity Inc. (NASDAQ: CELU), financed by a $5.5 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found